AR029072A1 - Bis-(n,n'-bis-(2-haloetil)amino fosforamidatos, un procedimiento para su preparacion, una composicion farmaceutica, y el uso de los mismos para la manufactura de medicamentos antitumorales - Google Patents
Bis-(n,n'-bis-(2-haloetil)amino fosforamidatos, un procedimiento para su preparacion, una composicion farmaceutica, y el uso de los mismos para la manufactura de medicamentos antitumoralesInfo
- Publication number
- AR029072A1 AR029072A1 ARP010102067A ARP010102067A AR029072A1 AR 029072 A1 AR029072 A1 AR 029072A1 AR P010102067 A ARP010102067 A AR P010102067A AR P010102067 A ARP010102067 A AR P010102067A AR 029072 A1 AR029072 A1 AR 029072A1
- Authority
- AR
- Argentina
- Prior art keywords
- bis
- haloethyl
- manufacture
- preparation
- antitumural
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- -1 AMINO PHOSPHORAMIDATES Chemical class 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 230000000259 anti-tumor effect Effects 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 125000004185 ester group Chemical group 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 150000008298 phosphoramidates Chemical class 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/22—Amides of acids of phosphorus
- C07F9/24—Esteramides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/22—Amides of acids of phosphorus
- C07F9/24—Esteramides
- C07F9/2454—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic
- C07F9/2458—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic of aliphatic amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/22—Amides of acids of phosphorus
- C07F9/24—Esteramides
- C07F9/2404—Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic
- C07F9/2408—Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic of hydroxyalkyl compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se refiere a Bis-(N, N'-bis (2-haloetil) amino) fosforamidatos, que comprende un compuesto representado por la formula (1) en la cual: X es un átomo de halogeno; Q es NH, O, SO2-O-, o S; y R es hidrogeno, alquilo inferior, alquilo inferior sustituido, arilo, R'CO-, R'SO2- en la cual R' es hidrogeno, alquilo inferior, arilo o heterociclo; o R-Q conjuntamente es cloro o un grupo éster o sales del mismo farmacéuticamente aceptable, un procedimiento para su preparacion, composiciones farmacéuticas . Los compuestos poseen actividades anti-tumorales o son capaces de ser modificados para tener actividades anti-tumorales, y por lo tanto, se refiere en particular al uso de los compuestos para la manufactura de medicamentos para el tratamiento de tumores especialmente para el tratamiento del cáncer.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US56318100A | 2000-05-02 | 2000-05-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR029072A1 true AR029072A1 (es) | 2003-06-04 |
Family
ID=24249433
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP010102067A AR029072A1 (es) | 2000-05-02 | 2001-05-02 | Bis-(n,n'-bis-(2-haloetil)amino fosforamidatos, un procedimiento para su preparacion, una composicion farmaceutica, y el uso de los mismos para la manufactura de medicamentos antitumorales |
Country Status (26)
| Country | Link |
|---|---|
| EP (2) | EP1607399B1 (es) |
| JP (1) | JP4249928B2 (es) |
| KR (1) | KR100729980B1 (es) |
| CN (1) | CN1182143C (es) |
| AR (1) | AR029072A1 (es) |
| AT (2) | ATE313549T1 (es) |
| AU (2) | AU6115301A (es) |
| BR (1) | BR0110553A (es) |
| CA (1) | CA2407606C (es) |
| CZ (1) | CZ20023615A3 (es) |
| DE (2) | DE60116081T2 (es) |
| DK (2) | DK1278759T3 (es) |
| EA (1) | EA006852B1 (es) |
| ES (2) | ES2337154T3 (es) |
| HK (2) | HK1050368A1 (es) |
| HU (1) | HUP0300688A3 (es) |
| IL (2) | IL152325A0 (es) |
| MX (1) | MXPA02010813A (es) |
| NO (2) | NO328854B1 (es) |
| NZ (1) | NZ522189A (es) |
| PL (1) | PL207005B1 (es) |
| PT (1) | PT1607399E (es) |
| TW (1) | TWI308569B (es) |
| UA (1) | UA74574C2 (es) |
| WO (1) | WO2001083496A1 (es) |
| ZA (1) | ZA200208591B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200600091A (en) | 2004-05-21 | 2006-01-01 | Telik Inc | Sulfonylethyl phosphorodiamidates |
| US8198247B2 (en) | 2004-12-21 | 2012-06-12 | Telik, Inc. | Process for and intermediates in the preparation of canfosfamide and its salts |
| US7655799B2 (en) | 2006-11-29 | 2010-02-02 | Telik, Inc. | 2{[2-(substituted amino)ethyl]sulfonyl}ethyl N,N,N',N'-tetrakis(2-chloroethyl)phosphorodiamidates |
| US7872134B2 (en) | 2007-12-12 | 2011-01-18 | Telik, Inc. | 2-{[2-(substituted amino)ethyl]sulfonyl}ethyl N,N-bis(2-chloroethyl)phosphorodiamidates |
| KR20160066557A (ko) * | 2008-03-14 | 2016-06-10 | 제넨테크, 인크. | 약물 저항성과 관련된 유전적 변이 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5556942A (en) * | 1991-04-29 | 1996-09-17 | Terrapin Technologies, Inc. | Glutathione S-transferase-activated compounds |
-
2001
- 2001-02-05 UA UA2002119554A patent/UA74574C2/uk unknown
- 2001-05-01 TW TW090110381A patent/TWI308569B/zh not_active IP Right Cessation
- 2001-05-02 AT AT01935025T patent/ATE313549T1/de active
- 2001-05-02 DK DK01935025T patent/DK1278759T3/da active
- 2001-05-02 AT AT05020467T patent/ATE455779T1/de active
- 2001-05-02 BR BR0110553-1A patent/BR0110553A/pt active Search and Examination
- 2001-05-02 ES ES05020467T patent/ES2337154T3/es not_active Expired - Lifetime
- 2001-05-02 CA CA002407606A patent/CA2407606C/en not_active Expired - Fee Related
- 2001-05-02 WO PCT/US2001/014290 patent/WO2001083496A1/en active IP Right Grant
- 2001-05-02 HU HU0300688A patent/HUP0300688A3/hu unknown
- 2001-05-02 CZ CZ20023615A patent/CZ20023615A3/cs unknown
- 2001-05-02 EP EP05020467A patent/EP1607399B1/en not_active Expired - Lifetime
- 2001-05-02 DE DE60116081T patent/DE60116081T2/de not_active Expired - Lifetime
- 2001-05-02 CN CNB018089623A patent/CN1182143C/zh not_active Expired - Fee Related
- 2001-05-02 PT PT05020467T patent/PT1607399E/pt unknown
- 2001-05-02 JP JP2001580921A patent/JP4249928B2/ja not_active Expired - Fee Related
- 2001-05-02 PL PL358155A patent/PL207005B1/pl not_active IP Right Cessation
- 2001-05-02 EA EA200201154A patent/EA006852B1/ru not_active IP Right Cessation
- 2001-05-02 IL IL15232501A patent/IL152325A0/xx unknown
- 2001-05-02 AR ARP010102067A patent/AR029072A1/es active IP Right Grant
- 2001-05-02 DE DE60141181T patent/DE60141181D1/de not_active Expired - Lifetime
- 2001-05-02 EP EP01935025A patent/EP1278759B1/en not_active Expired - Lifetime
- 2001-05-02 MX MXPA02010813A patent/MXPA02010813A/es active IP Right Grant
- 2001-05-02 AU AU6115301A patent/AU6115301A/xx active Pending
- 2001-05-02 AU AU2001261153A patent/AU2001261153B2/en not_active Ceased
- 2001-05-02 ES ES01935025T patent/ES2253380T3/es not_active Expired - Lifetime
- 2001-05-02 DK DK05020467.6T patent/DK1607399T3/da active
- 2001-05-02 KR KR1020027014577A patent/KR100729980B1/ko not_active IP Right Cessation
- 2001-05-02 NZ NZ522189A patent/NZ522189A/en not_active IP Right Cessation
-
2002
- 2002-10-16 IL IL152325A patent/IL152325A/en not_active IP Right Cessation
- 2002-10-23 ZA ZA200208591A patent/ZA200208591B/en unknown
- 2002-11-01 NO NO20025240A patent/NO328854B1/no not_active IP Right Cessation
-
2003
- 2003-03-31 HK HK03102283A patent/HK1050368A1/xx not_active IP Right Cessation
-
2006
- 2006-04-04 HK HK06104167.3A patent/HK1084119A1/xx not_active IP Right Cessation
-
2009
- 2009-11-18 NO NO20093371A patent/NO331833B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2350605C2 (ru) | Аналоги хиназолина в качестве ингибиторов рецепторных тирозинкиназ | |
| EA200500174A1 (ru) | Новые производные бензимидазола, полезные в качестве антипролиферативных агентов | |
| UY26872A1 (es) | Derivados de la 4- fenil piridina | |
| CY1109681T1 (el) | Υποκατεστημενα παραγωγα κιναζολινης ως αναστολεις των κινασων aurora | |
| BR0317435A (pt) | Derivados de pirimidina para o tratamento do crescimento celular anormal | |
| CA2445190A1 (en) | Indole, azaindole and related heterocyclic amidopiperazine derivatives | |
| DK1519724T3 (da) | Fredericamycin-derivater som lægemidler til behandling af tumorer | |
| UY29312A1 (es) | Piperazin-1-carboxamidas n,4,sustituidas y sus derivados, composiciones que los contienen, procedimientos de preparación y aplicaciones | |
| EA200100600A3 (ru) | Новые соединения дифенилмочевины, способ их получения и содержащие их фармацевтические композиции | |
| EA200100710A1 (ru) | 4-(аминометил)пиперидинбензамиды для лечения желудочно-кишечных расстройств | |
| BR0309342A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas | |
| ECSP066349A (es) | Inhibidores de transferasa de proteína de farnesilo novedosos como agentes antitumorales | |
| CY1105459T1 (el) | Συνθεσεις που πepιεχουν εποθιλονες και η χρηση τους για τη θepαπεια του καρκινοειδους συνδρομου | |
| ATE372995T1 (de) | Benzo(b)(1,4)dioxepinderivate | |
| IS5588A (is) | Æxliseyðandi miðlar | |
| MXPA05005790A (es) | Aminoalcoxiindoles como ligandos del receptor 5-ht6 para el tratamiento de enfermedades del sistema nervioso central. | |
| BR0308071A (pt) | Inibidores da protéina farnesil transferase como agentes antitumores | |
| SG145570A1 (en) | 4-æ7-halo-2-quino(xa-)linyloxy!phenoxy-propionic acid derivatives as antineoplastic agents | |
| ID23954A (id) | Tetrahidrogama-karbolin | |
| AR029072A1 (es) | Bis-(n,n'-bis-(2-haloetil)amino fosforamidatos, un procedimiento para su preparacion, una composicion farmaceutica, y el uso de los mismos para la manufactura de medicamentos antitumorales | |
| ATE344230T1 (de) | Triphenylbutenderivate zur behandlung von neurologischen störungen | |
| BG106847A (en) | Substituted piperazine derivatives as mtp inhibitors | |
| BR0204489A (pt) | Derivados de rodamina, composto, intermediários, processos para a sìntese de derivados de rodamina, uso de um composto, métodos para a terapia fotodinâmica de pacientes, para purga in vitro da medula óssea humana, para o tratamento de leucemias, de distúrbios imunológicos e de infecções geradas por bactérias e para prevenção de doença, composição farmacêutica fotoativável, composição e solução bactericida e medicamento. | |
| ATE554764T1 (de) | Wirkungsvolle vereinfachte derivate von immunosuppressiva | |
| PL432858A1 (pl) | Związki stanowiące C20-modyfikowane pochodne salinomycyny, sposób ich otrzymywania, kompozycja je zawierająca, zastosowanie tych związków oraz sposób otrzymywania produktu pośredniego |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |